What factors need to be considered when assessing the financial costs of medicines

A. S. Fedorenko; A. T. Burbello; M. V. Pokladova; M. A. Ivanova

doi:10.17816/mechnikov201810264-72

HERALD of North-Western State Medical University named after I.I. Mechnikov ›› 2018, Vol. 10 ›› Issue (2) :64 -72. DOI: 10.17816/mechnikov201810264-72

Articles

research-article

What factors need to be considered when assessing the financial costs of medicines

Author information +

History +

PDF

Abstract

The article presents possible approaches to assessing the financial costs of medicines. The results of the ABC/VEN and ATC DDD analyzes recommended by the Ministry of Health of the Russian Federation and the World Health Organization (WHO) in assessing the financial costs of medicines in a large multidisciplinary hospital are described. The evaluation of ABC/VEN and ATC/DDD analyzes, their advantages and disadvantages is given. It is shown that the ABC/VEN analysis gives only a general idea of planning financial expenditures and ATC/DDD about real drug consumption in the treatment of one patient. The financial costs of treating one patient vary significantly and depend on many factors: disease nosology, severity, division profile, etc. It was determined which factors should be taken into account both in estimating the cost of medicines and in planning financial expenditures for the next year.

Keywords

planning financial expenditures of medicines / ABC/VEN analyze / ATC DDD analyze

Cite this article

Download citation ▾

A. S. Fedorenko, A. T. Burbello, M. V. Pokladova, M. A. Ivanova. What factors need to be considered when assessing the financial costs of medicines. HERALD of North-Western State Medical University named after I.I. Mechnikov, 2018, 10(2): 64-72 DOI:10.17816/mechnikov201810264-72

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]

Приказ Министерства здравоохранения Российской Федерации № 494 от 22 октября 2003 г. «О совершенствовании деятельности врачей - клинических фармакологов» [Prikaz Ministerstva zdravookhraneniya Rossiyskoy Federatsii No 494 ot 22 oktyabrya 2003 g “O sovershenstvovanii deyatel’nosti vrachey klinicheskikh farmakologov” (In Russ.)] Доступно по: http://docs.cntd.ru/document/901880261. Ссылка активна на 03.06.2018.

[2]	Использование ATC/DDD анализа. Available at: https://www.whocc.no/use_of_atc_ddd. Accessed June 3, 2018.

[3]

Приказ Министерства здравоохранения и социального развития Российской Федерации № 433 от 30 мая 2006 г. «Об утверждении стандарта медицинской помощи больным псориазом». [Order of the Ministry of Health and Social Development of the Russian Federation No 433 of May 30, 2006 “On the approval of the standard of medical care for patients with psoriasis” (In Russ.)] Доступно по: http://docs.cntd.ru/document/901988361. Ссылка активна на 03.06.2018.

[4]	Щепин О.П., Медик В.А. Общественное здоровье и здравоохранение: учебник. - М.: ГЭОТАР-Медиа, 2012. - 592 с. [Chepin OP, Medik VA. Obshchestvennoye zdorov’ye i zdravookhraneniye: uchebnik. Moscow: GEOTAR; 2012. 592 p. (In Russ.)]

[5]

Омельяновский В.В. Модели организации ОТЗ в условиях российской системы здравоохранения // Медицинские технологии. Оценка и выбор. - 2013. - № 3(13). - С. 8-14. [Omelyanovsky VV. Models for Organizing HTA in the Context of the Russian Health Care. Research. Analysis Examination. 2013;3(13):8-14. (In Russ.)]

[6]	Проект профессионального стандарта врача - клинического фармаколога. Доступно по: http://szgmu.ru/rus/m/3657/. Ссылка активна на 03.06.2018. [Proekt professional’nogo standarta vracha klinicheskogo farmakologa. Dostupno po: http://szgmu.ru/rus/m/3657/. Ssylka aktivna na 03.06.2018. (In Russ.)]